Site Index

Clinical Trial Search Engines

Complementary Medicine

Contributions/Donations

Cushings Syndrome Treatment

DCA - Dichloroacetate

EGFR

Financial Help

Flame Retardants

Fundraising

Gemcitabine (Gemzar®)

General Cancer Education

Immunoviva

Intro to Adrenocortical Carcinoma

Non-Prescription Anti-Cancer Drugs

RU 486 - Mifepristone

Tetrathiomolybdate (TM)

TGEN - Translational Genomics

Thalidomide

What is Adrenocortical Carcinoma

Videos

What is Adrenocortical Carcinoma?
Adrenal Cancer Overview Adrenocortical Carcinoma for Patients Adrenocortical Carcinoma for Healthcare Professionals University of Michigan Comprehensive Cancer Center ’s Adrenal Cancer Information Guide Targeted Therapies Overview
ACC Medical Information
Physicians American Cancer Society ACC Guide Help dedicated to patients, caregivers, physicians, and researchers The Netherlands Journal of Medicine - Treatment, Therapy TGen ACC Symposium Presentations Recommendations for surveillance after surgical resection of selected adrenal nodules Emerging drugs for adrenocortical carcinoma National Cancer Institute Med News Endocrine Web Adrenocortical Carcinoma Cancer Genetics Site PubMed Search - Adrenocortical Carcinoma Abstracts European Network for the Study of Adrenal Tumours Germany-wide network of experts on adrenal diseases UCLA Endocrine Healthcare List of Reputable Web Resources
Molecular Profiling for Targetted Therapies
MOLECULAR PROFILING STUDY or SCRI-CA-001 Study (Formerly known as the Bisgrove Trial). Joyce Ingold RN MSN OCN TGen Clinical Research Services Patient Care Coordinator Office Phone: 480-323-1339 jingold@shc.org ATAC Fund ACC Tumor Analysis and Tissue Bank- Free for Eligible Patients Molecular Profiling Institute Rational Therapeutics Chemo-Sensitivity Testing Drug Resistance and Cytoxicity Testing ABC News Fighting Disease with DNA Predictive markers help oncologists match patients with the most effective treatments. Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors. Gene Expression Profiling of Human Adrenocortical Tumors Using Complementary Deoxyribonucleic Acid Microarrays Identifies Several Candidate Genes as Markers of Malignancy Review: Side Effects of Approved Molecular Targeted Therapies in Solid Cancers
ACC Chemo and Clinical Trials also see Mitotane Section
Systemic chemotherapy for adrenocortical carcinoma: comparative responses to conventional first-line therapies. Adjuvant Mitotane Treatment for Adrenocortical Carcinoma MOLECULAR PROFILING STUDY or SCRI-CA-001 Study (Formerly known as the Bisgrove Trial). Joyce Ingold RN MSN OCN TGen Clinical Research Services Patient Care Coordinator Office Phone: 480-323-1339 jingold@shc.org Treatment Study Using Bevacizumab [AVASTIN] for Patients With Adrenocortical Carcinoma FIRM-ACT Italian Protocol Modified Firm Act Study - SIRAC Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial [Italian Protocol] Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC) Tariquidar, Mitotane, Doxorubicin, Vincristine, and Etoposide Plus Surgery in Treating Patients With Recurrent, Metastatic, or Primary Unresectable Adrenocortical Cancer CASE 2. Response in a Patient With Metastatic Adrenal Cortical Carcinoma With Thalidomide Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine. Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
Solid Tumor Trials
ADH-1 Exherin Streptozocin and o,p'DDD in the treatment of adrenocortical cancer patients: Long-term survival in its adjuvant use Cisplatin-induced peripheral neuropathy: Neuroprotection by erythropoietin without affecting tumour growth A Study of Oral PX-478 in Advanced Solid Tumors or Lymphoma One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy Phase 1 Study With Sorafenib and Sirolimus Peripheral Stem Cell Transplant and White Blood Cell Transfusions in Treating Patients With Refractory Metastatic Solid Tumors
Prognosis Articles
Long-Term Survival After Complete Resection and Repeat Resection in Patients With Adrenocortical Carcinoma Adrenocortical Carcinoma: Clinical, Morphologic, and Molecular Characterization Clinical and Biological Features in the Prognosis of Adrenocortical Cancer: Poor Outcome of Cortisol-Secreting Tumors in a Series of 202 Consecutive Patients Pathologic Features of Prognostic Significance for Adrenocortical Carcinoma After Curative Resection
Mitotane
General Mitotane Info Adjuvant Mitotane Treatment for Adrenocortical Carcinoma Mitotane - Drug Boosts Adrenal Cancer Survival Mitotane Absorption - Chocolate, Emulsion, and Milk Low-Dose Monitored Mitotane Treatment Achieves the Therapeutic Range with Manageable Side Effects in Patients with Adrenocortical Cancer Mitotane and Cholesterol Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines

[ACC Community][Find Physicians][Treatment Options][Research Tools][Natural Medicine]

info@adrenalcancersupport.org